Psyence Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	1.29	0.33
Operating Expenses	1.29	0.33
Operating Income	-1.29	-0.33
Other Expense / Income	-9.31	-8.56
Pretax Income	8.01	8.23
Net Income	8.01	8.23
Net Income Growth	-2.63%	-
Shares Outstanding (Basic)	33	13
Shares Outstanding (Diluted)	33	13
Shares Change	156.47%	-
EPS (Basic)	0.25	0.65
EPS (Diluted)	0.25	0.65
EPS Growth	-61.54%	-
Free Cash Flow	-0.52	-0.84
Free Cash Flow Per Share	-0.02	-0.07
EBITDA	8.01	8.23
EBIT	8.01	8.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).